Steve  Chaussy net worth and biography

Steve Chaussy Biography and Net Worth

Chief Financial Officer of BioSig Technologies
Mr. Chaussy has served as Chief Financial Officer of BioSig Technologies, Inc., since May of 2011, making him one of the Company’s most veteran executives. He brings an impressive array of professional experiences, detailed protocols, and an adept understanding of the financial operations of public companies.

Mr. Chaussy has an extensive entrepreneurial growth and development background from working for Penske Truck Leasing Co., L.P., a Penske Corporation subsidiary, where his improvements of management and reporting tools allowed the Company to double in size. Since 2005, Mr. Chaussy has been the sole proprietor of Anna & Co., Inc., a consulting company that offers services to small publicly traded companies. Anna & Co., Inc. provides general financial and accounting services, emphasizing SEC reporting and compliance, to companies that lack sufficient resources to hire full-time employees to offer such services. From 2001 to 2005, Mr. Chaussy provided services as both a Chief Financial Officer and a consultant to small publicly traded companies. Before 2001, Mr. Chaussy served as the chief financial officer for a large private distribution and wholesaling Company, where he gained international experience.


Mr. Chaussy is a graduate of Virginia Polytechnic Institute and State University and is a licensed, certified public accountant in Virginia, California, and Florida.

What is Steve Chaussy's net worth?

The estimated net worth of Steve Chaussy is at least $68,751.93 as of August 22nd, 2022. Mr. Chaussy owns 104,012 shares of BioSig Technologies stock worth more than $68,752 as of March 29th. This net worth approximation does not reflect any other investments that Mr. Chaussy may own. Learn More about Steve Chaussy's net worth.

How do I contact Steve Chaussy?

The corporate mailing address for Mr. Chaussy and other BioSig Technologies executives is 54 WILTON ROAD, WESTPORT CT, 06880. BioSig Technologies can also be reached via phone at (230) 409-5444 and via email at [email protected]. Learn More on Steve Chaussy's contact information.

Has Steve Chaussy been buying or selling shares of BioSig Technologies?

Steve Chaussy has not been actively trading shares of BioSig Technologies over the course of the past ninety days. Most recently, on Monday, August 22nd, Steve Chaussy bought 800 shares of BioSig Technologies stock. The stock was acquired at an average cost of $11.30 per share, with a total value of $9,040.00. Following the completion of the transaction, the chief financial officer now directly owns 104,012 shares of the company's stock, valued at $1,175,335.60. Learn More on Steve Chaussy's trading history.

Who are BioSig Technologies' active insiders?

BioSig Technologies' insider roster includes Steve Chaussy (Chief Financial Officer), and Kenneth Londoner (CEO). Learn More on BioSig Technologies' active insiders.

Are insiders buying or selling shares of BioSig Technologies?

During the last twelve months, BioSig Technologies insiders bought shares 1 times. They purchased a total of 600 shares worth more than $7,020.00. The most recent insider tranaction occured on June, 12th when CEO Kenneth L Londoner bought 600 shares worth more than $7,020.00. Insiders at BioSig Technologies own 9.3% of the company. Learn More about insider trades at BioSig Technologies.

Information on this page was last updated on 6/12/2023.

Steve Chaussy Insider Trading History at BioSig Technologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/22/2022Buy800$11.30$9,040.00104,012View SEC Filing Icon  
5/21/2021Buy200$33.85$6,770.0083,312View SEC Filing Icon  
12/1/2020Buy200$43.50$8,700.0068,112View SEC Filing Icon  
3/16/2020Buy400$26.10$10,440.0067,526View SEC Filing Icon  
11/6/2019Buy200$68.40$13,680.00
11/21/2018Buy100$38.00$3,800.00View SEC Filing Icon  
8/20/2018Buy100$24.60$2,460.00View SEC Filing Icon  
5/31/2018Buy500$17.20$8,600.00View SEC Filing Icon  
3/29/2018Buy500$16.00$8,000.00View SEC Filing Icon  
3/13/2018Buy453$13.90$6,296.70View SEC Filing Icon  
3/7/2018Buy610$14.00$8,540.00View SEC Filing Icon  
3/1/2018Buy500$13.70$6,850.00View SEC Filing Icon  
12/21/2017Buy250$14.80$3,700.00View SEC Filing Icon  
8/22/2017Buy1,042$13.90$14,483.8062,876View SEC Filing Icon  
5/19/2016Buy40$18.10$724.0042,376View SEC Filing Icon  
1/12/2016Buy300$11.90$3,570.0042,336View SEC Filing Icon  
12/24/2015Buy400$14.00$5,600.0032,236View SEC Filing Icon  
12/18/2015Buy500$12.50$6,250.0031,836View SEC Filing Icon  
12/16/2015Buy500$11.70$5,850.0031,336View SEC Filing Icon  
See Full Table

Steve Chaussy Buying and Selling Activity at BioSig Technologies

This chart shows Steve Chaussy's buying and selling at BioSig Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioSig Technologies Company Overview

BioSig Technologies logo
BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
Read More

Today's Range

Now: $0.66
Low: $0.65
High: $0.77

50 Day Range

MA: $0.95
Low: $0.32
High: $2.69

2 Week Range

Now: $0.66
Low: $0.26
High: $16.50

Volume

268,652 shs

Average Volume

351,138 shs

Market Capitalization

$5.94 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.22